9999999997-19-005536.txt : 20190618 9999999997-19-005536.hdr.sgml : 20190618 20190618120214 ACCESSION NUMBER: 9999999997-19-005536 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190618 DATE AS OF CHANGE: 20190618 ACTION DATE: 20190618 RECEIVED DATE: 20190618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDO HEALTH SOLUTIONS INC. CENTRAL INDEX KEY: 0001100962 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134022871 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-15989 FILM NUMBER: 19903024 BUSINESS ADDRESS: STREET 1: 1400 ATWATER DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 4842160000 MAIL ADDRESS: STREET 1: 1400 ATWATER DRIVE CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: ENDO PHARMACEUTICALS HOLDINGS INC DATE OF NAME CHANGE: 19991214 CT ORDER 1 filename1.pdf begin 644 filename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